EU releases AI Act transparency guidelines, affecting health-tech developers
The European Commission has published new guidelines to help providers and users of artificial intelligence systems meet the transparency obligations set out in the EU AI Act.
The document explains the required disclosures and provides examples of situations where exemptions may apply.
While the guidance is not limited to any sector, companies that incorporate AI into medical devices or digital health solutions will need to evaluate their compliance with the rules.
The aim is to clarify expectations and promote consistent implementation of the transparency requirements across the European Union.
This writeup was produced by pharmadog from original reporting by raps.
Original headline: “European Commission publishes guideline on transparency obligations under AI Act”
read at raps ↗
comments(0)
5-min edit window · permanent after that